Market Tracker

07/25 5:16pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.26
Delayed Data
As of Jul 25
 -0.12 / -5.04%
Today’s Change
1.26
Today|||52-Week Range
6.49
-40.84%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close2.38
Today’s open2.33
Day’s range2.24 - 2.35
Volume11,154
Average volume (3 months)67,133
Market cap$15.6M
Dividend yield--
Data as of 3:59pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+73.42%
Earnings growth (this year)+29.52%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales558.44
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
WGBSWaferGen Bio-systems...+0.06+7.12%
CSBRChampions Oncology I...+0.10+4.79%
BNTCBenitec Biopharma Lt...-0.02-1.08%
RGBPRegen BioPharma Inc-0.00-2.10%
Data as of 4:00pm ET, 07/25/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$34.0K
Annual profit (last year)-$10.2M
Net profit margin-30,067.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts